Fort Worth, TX, United States of America

Mark T Dupriest


Average Co-Inventor Count = 2.0

ph-index = 2

Forward Citations = 29(Granted Patents)


Company Filing History:


Years Active: 1990-1997

Loading Chart...
6 patents (USPTO):Explore Patents

Title: Mark T Dupriest: Innovator in Ophthalmic Solutions

Introduction

Mark T Dupriest is a notable inventor based in Fort Worth, Texas. He has made significant contributions to the field of ophthalmology, particularly in the development of methods and compositions for controlling intraocular pressure. With a total of six patents to his name, Dupriest's work has had a meaningful impact on eye care.

Latest Patents

Dupriest's latest patents include "Substantially pure apraclonidine - Compositions containing, and methods for controlling intraocular pressure with, substantially pure apraclonidine." This patent discloses innovative methods and compositions aimed at effectively managing intraocular pressure. Another significant patent is "Methods and compositions for controlling intraocular pressure with - Compositions and methods for controlling intraocular pressure using transition metal complexes." This patent highlights the topical ophthalmic and systemic administration of transition metal complexes, showcasing Dupriest's commitment to advancing ophthalmic treatments.

Career Highlights

Throughout his career, Dupriest has worked with Alcon Laboratories, Inc., a leading company in eye care products. His experience in this esteemed organization has allowed him to refine his expertise and contribute to groundbreaking innovations in the field.

Collaborations

Dupriest has collaborated with notable professionals in the industry, including Hans R Moll and Daniel Kuzmich. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and advancements in ophthalmic research.

Conclusion

Mark T Dupriest stands out as a prominent inventor in the field of ophthalmology, with a focus on innovative solutions for controlling intraocular pressure. His contributions through patents and collaborations continue to shape the future of eye care.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…